Abnormalities in B cells play pivotal roles in the pathogenesis of systemic lupus
erythematosus (SLE) and lupus nephritis (LN). Breach in central and peripheral tolerance …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …

Abstract Purpose of Review Discuss the prognostic significance of kidney flares in patients
with lupus nephritis, associated risk factors, and possible preventative strategies. Recent …

Objectives To evaluate changes in demographic, clinical and histological presentation, and
prognosis of lupus nephritis (LN) over time. Patients and methods We studied a multicentre …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

The optimal duration of maintenance immunosuppressive therapy for patients with lupus
nephritis who have achieved clinical remission has not been established. Furthermore …

Background Long-term data pertaining to rituximab as add-on therapy in childhood-onset
lupus nephritis (cLN) is scarce. Methods A retrospective cohort study was conducted on all …

Objectives To determine the effect of antimalarial agents (AMA) and different doses and
pharmaceutical forms of belimumab on preventing renal flares in patients with SLE treated …

Background: Renal flare of lupus nephritis (LN) is strongly associated with poor kidney
outcomes, and predicting renal flare and stratifying its risk are important for clinical decision …